CD33-directed Immunoconjugate [EPC] - N0000175571
Pharmacologic Class Information
Pharmacologic Code | N0000175571 |
Pharmacologic Name | CD33-directed Immunoconjugate |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with CD33-directed Immunoconjugate
The table contains 1 products whose active ingredient are classified under the same pharmacologic class CD33-directed Immunoconjugate [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0008-4510 | Mylotarg | Non-Proprietary Name: Gemtuzumab Ozogamicin | Injection, Powder, Lyophilized, For Solution | Intravenous | Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. | ACTIVE |